Aviva Katzav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aviva Katzav has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Chaim G. Pick
Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University, Israel
3 shared publicationsJoab Chapman
Department of Neurology and Joseph Sagol Neuroscience Center, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer 52621, Israel; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Israel
3 shared publicationsAssaf Menachem
Department of Neurology and Joseph Sagol Neuroscience Center, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer 52621, Israel; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Israel
2 shared publications- Chaim G. Pick
Department of Anatomy and Anthropology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
2 shared publications - Joab Chapman
Sheba Medical Center, Ramat Gan, Israel; Tel Aviv University, Tel Aviv, Israel, Israel
2 shared publications - Nicola Maggio
Department of Neurology, The Chaim Sheba Medical Center, Ramat Gan 52626202, Israel
2 shared publications
Latest Publications
- 15 October 2016
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 33 (20) , 1848-1854
Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes
Minimal traumatic brain injury (mTBI) is partially defined by the existence of retrograde amnesia and is associated with microscopic bleeds containing activated coagulation factors. In a previous study, we have found that mTBI immediately releases thrombin like activity in the brain, which induces amnesia by activating Protease Activated Receptor 1 (PAR-1) and blocking Long Term Potentiation (LTP). In the present study we assessed the effects of mTBI on thrombin and PAR-1 levels in the brain using the same model. Following the immediate elevation, thrombin activity returned to baseline 1 hour following the trauma and increased again 72 hours later (42% relative to control, p<0.005). These changes were associated with a significant increase in PAR-1 levels 24 hours (17%, p<0.05) and 72 hours (20%, p<0.05) following the trauma. Interestingly, the late elevation in thrombin-like activity was also associated with elevation of the major CNS thrombin inhibitor protease nexin-1, (PN-1) 72 hours following mTBI (10%, p<0.005). When thrombin was injected into the brain ventricles, an increased sensitivity to seizure like activity was detected at 72 hours post mTBI. The results are compatible with astrocyte activation following mTBI resulting in increased thrombin secretion, PAR-1 expression and seizure sensitivity.
- 15 October 2016
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 33 (20) , 1848-1854
Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes
Minimal traumatic brain injury (mTBI) is partially defined by the existence of retrograde amnesia and is associated with microscopic bleeds containing activated coagulation factors. In a previous study, we have found that mTBI immediately releases thrombin like activity in the brain, which induces amnesia by activating Protease Activated Receptor 1 (PAR-1) and blocking Long Term Potentiation (LTP). In the present study we assessed the effects of mTBI on thrombin and PAR-1 levels in the brain using the same model. Following the immediate elevation, thrombin activity returned to baseline 1 hour following the trauma and increased again 72 hours later (42% relative to control, p<0.005). These changes were associated with a significant increase in PAR-1 levels 24 hours (17%, p<0.05) and 72 hours (20%, p<0.05) following the trauma. Interestingly, the late elevation in thrombin-like activity was also associated with elevation of the major CNS thrombin inhibitor protease nexin-1, (PN-1) 72 hours following mTBI (10%, p<0.005). When thrombin was injected into the brain ventricles, an increased sensitivity to seizure like activity was detected at 72 hours post mTBI. The results are compatible with astrocyte activation following mTBI resulting in increased thrombin secretion, PAR-1 expression and seizure sensitivity.
- 1 December 2014
- Published by Elsevier in Journal of Autoimmunity
- Vol. 55, 86-93
IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome
- 1 December 2014
- Published by Elsevier in Journal of Autoimmunity
- Vol. 55, 86-93
IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome
- Open Access
- 4 April 2013
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1) , 92
Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
We investigated interactions between genetically and autoimmune-mediated coagulopathies by inducing experimental antiphospholipid syndrome (eAPS) in mice carrying the factor V Leiden (FVL) mutation.
- 4 April 2013
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1) , 92
Open AccessCoagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
We investigated interactions between genetically and autoimmune-mediated coagulopathies by inducing experimental antiphospholipid syndrome (eAPS) in mice carrying the factor V Leiden (FVL) mutation.
- 17 January 2013
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 45 (2) , 248-255
Immunoglobulin-Mediated Neuro-Cognitive Impairment: New Data and a Comprehensive Review
Excessive influx of immunoglobulin (IgG) into the brain has been reported to induce central nervous system (CNS) dysfunction. Depressed patients may exhibit immune activation manifested by elevated inflammatory markers and pro-inflammatory cytokines. The brain and especially the limbic system contain high concentrations of high affinity Fc receptors. We reviewed the literature on this phenomena and present data on the behavioral effects of pooled normal IgG on the brain. Many disease states are associated with depression and we examined whether this may be linked to high IgG influx. Female Balb/C mice were injected intra-cerbroventricularly with human immunoglobulin whole molecule, or human IgG F(ab′)2 or Fc fragments. Control mice were injected with saline. The four groups were subjected to behavioral (staircase, forced swimming test, and elevated plus maze) and cognitive tests (passive avoidance test). IgG-injected mice exhibited depression-like behavior as reflected by significantly higher immobility time in the forced swimming test (p < 0.05) and hyperactive behavior as reflected by higher number of stairs climbed in the staircase test compared to controls (p < 0.01). Fc-fragments-injected mice showed hyperactive behavior as reflected by both higher number of stairs climbed and rearing events in the staircase test compared to controls. The results indicate that high levels of normal IgG in the cerebrospinal fluid can cause hyperactivity and depression-like behavior. The mechanism involved in these CNS manifestations include possibly Fc receptor binding.
- 17 January 2013
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 45 (2) , 248-255
Immunoglobulin-Mediated Neuro-Cognitive Impairment: New Data and a Comprehensive Review
Excessive influx of immunoglobulin (IgG) into the brain has been reported to induce central nervous system (CNS) dysfunction. Depressed patients may exhibit immune activation manifested by elevated inflammatory markers and pro-inflammatory cytokines. The brain and especially the limbic system contain high concentrations of high affinity Fc receptors. We reviewed the literature on this phenomena and present data on the behavioral effects of pooled normal IgG on the brain. Many disease states are associated with depression and we examined whether this may be linked to high IgG influx. Female Balb/C mice were injected intra-cerbroventricularly with human immunoglobulin whole molecule, or human IgG F(ab′)2 or Fc fragments. Control mice were injected with saline. The four groups were subjected to behavioral (staircase, forced swimming test, and elevated plus maze) and cognitive tests (passive avoidance test). IgG-injected mice exhibited depression-like behavior as reflected by significantly higher immobility time in the forced swimming test (p < 0.05) and hyperactive behavior as reflected by higher number of stairs climbed in the staircase test compared to controls (p < 0.01). Fc-fragments-injected mice showed hyperactive behavior as reflected by both higher number of stairs climbed and rearing events in the staircase test compared to controls. The results indicate that high levels of normal IgG in the cerebrospinal fluid can cause hyperactivity and depression-like behavior. The mechanism involved in these CNS manifestations include possibly Fc receptor binding.
- 10 January 2012
- Published by SAGE Publications in Lupus
- Vol. 21 (2) , 210-216
Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome
Adjuvants may induce autoimmune diseases in susceptible individuals, a phenomenon recently defined as autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Patients with both antiphospholipid antibodies (aPL) and the genetic coagulopathy factor V Leiden (FVL) are frequently found. We therefore evaluated whether adjuvant can induce aPL in heterozygous FVL mice. aPL were measured in naïve mice and at 1 and 5 months after immunization with either complete or incomplete Freund’s adjuvant (CFA, IFA) in FVL and control C57/B6 background mice. We defined antibody levels 3 SD above the mean of C57/B6 mice immunized with adjuvant as positive (specificity of 99%). For β2GPI-dependent aPL, 28.6% (6/21) of FVL mice 5 months after immunization with adjuvant (both IFA and CFA) were positive compared with 4.8% (1/22) of FVL mice 1 month after adjuvant and 0% of naïve FVL and C57/B6 mice (0/16, p < 0.001). aPL levels correlated with behavioral hyperactivity in the staircase test. FVL mice immunized with adjuvant did not develop β2GPI-independent aPL. We hypothesize that the FVL aPL association is not a coincidence, but that chronic coagulation defects combined with external inflammatory stimuli analogous to adjuvant may induce aPL and also antiphospholipid syndrome, thus supporting the notion of ASIA.
- 10 January 2012
- Published by SAGE Publications in Lupus
- Vol. 21 (2) , 210-216
Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome
Adjuvants may induce autoimmune diseases in susceptible individuals, a phenomenon recently defined as autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Patients with both antiphospholipid antibodies (aPL) and the genetic coagulopathy factor V Leiden (FVL) are frequently found. We therefore evaluated whether adjuvant can induce aPL in heterozygous FVL mice. aPL were measured in naïve mice and at 1 and 5 months after immunization with either complete or incomplete Freund’s adjuvant (CFA, IFA) in FVL and control C57/B6 background mice. We defined antibody levels 3 SD above the mean of C57/B6 mice immunized with adjuvant as positive (specificity of 99%). For β2GPI-dependent aPL, 28.6% (6/21) of FVL mice 5 months after immunization with adjuvant (both IFA and CFA) were positive compared with 4.8% (1/22) of FVL mice 1 month after adjuvant and 0% of naïve FVL and C57/B6 mice (0/16, p < 0.001). aPL levels correlated with behavioral hyperactivity in the staircase test. FVL mice immunized with adjuvant did not develop β2GPI-independent aPL. We hypothesize that the FVL aPL association is not a coincidence, but that chronic coagulation defects combined with external inflammatory stimuli analogous to adjuvant may induce aPL and also antiphospholipid syndrome, thus supporting the notion of ASIA.